CD274 and neoplasm: This test evaluates PD-L1 expression levels, CD8+ T-cell tumor infiltration pattern by immunohistochemistry, mutational burden by whole-exon DNA-seq, as well as the abundance of 394 immune transcripts by RNA-seq.